Torchmark Corp. (TMK) is Trading Higher on Unusual Volume for February 04

Equities Staff |

Torchmark Corp. (TMK) experienced unusually high volume on Feb. 04, as the stock gained 0.06% to a closing price of $52.27. The stock saw 1.45 million shares trade hands over the course of the day on 12,660 trades. Given that the stock’s average daily volume over the last month has been 770,802 shares a day, this represents a pretty substantial spike over the norm.

Torchmark Corp. has a P/B ratio of 1.51. It also has a P/E ratio of 13.5. The stock has traded between $63.26 and $50.56 over the last 52-weeks, its 50-day SMA is now $56.52, and its 200-day SMA $57.76.

Torchmark Corp is an insurance holding company. It markets individual life and supplemental health insurance and to limited extent annuities, to middle income households throughout the United States.

Headquartered in McKinney, TX, Torchmark Corp. has 2,980 employees and is currently under the leadership of CEO Larry M. Hutchison / Roger C. Smith / Gary L. Coleman.

For a complete fundamental analysis analysis of Torchmark Corp., check out’s Stock Valuation Analysis report for TMK. To see the latest independent stock recommendations from’s analysts, visit our Research section.


The Russell 3000 is not well known outside the world of finance, but it’s one of the strongest indices out there for getting a broad sense of the stock market. Unlike the better-known Dow Jones Industrial Average or S&P 500, membership on the Russell 3000 isn’t selected by committee. It’s simply the 3,000 most valuable companies in the country.

With 3,000 stocks making up the index, it gives a broad look at the markets, including the small-and mid-cap companies that aren’t on the Dow or the S&P 500. And with a rules-based system for determining membership, there’s no bias that could potentially limit membership. That’s why many financial professionals will turn to the Russell 3000 long before the better-known indices when trying to take the temperature of the market.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Breathtec BioMedical Inc.

Breathtec Biomedical Inc is a medical diagnostics company. It is engaged in developing & commercializing breath analysis devices for the early detection of infections & life threatening diseases including cancers,…

Private Markets

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…

CF0005, LLC dba Mesa-Marshall #1-2

MESA Resources, Inc. ("MESA") is sponsoring the development of the oil & gas well completion project "Mesa-Marshall #1-2". MESA, founded in 1992, is engaged in the acquisition, exploration and development…